Sign In
Buy KURA
$8.66
-0.315 (-3.51%)
At Close: Jun 03, 2026
Kura Oncology Announces Commencement of Public Offering of Common Stock
08:01pm, Tuesday, 05'th May 2020
Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it has commenced an u
Kura Oncology, Inc. (KURA) Q1 2020 Earnings Call Transcript
03:30pm, Tuesday, 05'th May 2020
Joining me on the call from Kura are Dr. Troy Wilson, our President and Chief Executive Officer and Dr. Marc Grasso, our Chief Financial Officer and Chief Business Officer. Jim Basta, our Chief Legal
Edited Transcript of KURA earnings conference call or presentation 4-May-20 8:30pm GMT
06:35am, Tuesday, 05'th May 2020
Q1 2020 Kura Oncology Inc Earnings Call
Kura Oncology Reports First Quarter 2020 Financial Results
08:05pm, Monday, 04'th May 2020
Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today reported first quarter 2020 financia
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Kura Oncology (KURA) Set to Announce Earnings on Monday
06:36am, Saturday, 02'nd May 2020
Kura Oncology (NASDAQ:KURA) is scheduled to be posting its quarterly earnings results after the market closes on Monday, May 4th. Analysts expect Kura Oncology to post earnings of ($0.42) per share fo
Kura Oncology to Report First Quarter 2020 Financial Results
11:30am, Wednesday, 29'th Apr 2020
Kura Oncology, Inc. (KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced that it will report first quarter
Kura Oncology to Report First Quarter 2020 Financial Results
11:30am, Wednesday, 29'th Apr 2020
SAN DIEGO, April 29, 2020 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development...
82 Biggest Movers From Yesterday
08:30am, Wednesday, 29'th Apr 2020
Gainers
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) shares climbed 69.4% to close at $19.50 on Tuesday after the company presented positive preclinical and initial clinical data...
Zacks Investment Research Downgrades Kura Oncology (NASDAQ:KURA) to Hold
07:26am, Wednesday, 29'th Apr 2020
Kura Oncology (NASDAQ:KURA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, �
6 Stocks To Watch: AMC, BLDR, CREX, KURA, NGL, RRGB
12:00am, Wednesday, 29'th Apr 2020
Stocks Analysis by Harry Boxer covering: MGM Resorts International, Fluor Corporation, Builders FirstSource Inc, Avadel Pharmaceuticals PLC. Read Harry Boxer's latest article on Investing.com
Why Kura Oncology Is Skyrocketing Today
07:09pm, Tuesday, 28'th Apr 2020
Shares of Kura Oncology (NASDAQ: KURA) -- a clinical-stage biopharmaceutical company that focuses on developing cancer treatments -- were up by 42.6% as of 1:49 p.m. EDT on Tuesday. The company did n
56 Stocks Moving In Tuesday's Mid-Day Session
04:27pm, Tuesday, 28'th Apr 2020
Gainers
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) shares jumped 68.6% to $19.40 after the company presented positive preclinical and initial clinical data for SNDX-5613, its...
Zacks Investment Research Upgrades Kura Oncology (NASDAQ:KURA) to "Buy"
08:44am, Tuesday, 28'th Apr 2020
Kura Oncology (NASDAQ:KURA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Zacks.com reports. The firm currently has a $12.00
Analyzing Kura Oncology (NASDAQ:KURA) & Roche Holdings AG Basel (NASDAQ:RHHBY)
06:18am, Monday, 27'th Apr 2020
Roche Holdings AG Basel (OTCMKTS:RHHBY) and Kura Oncology (NASDAQ:KURA) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of th
